1Stuber F, Peterson M, Bokelman F, et al. A genomic polymorphism within tumor necosis factor locus influences plasma tumor necrosis factor - alpha concentrations and outcome of patients with severe sepsis [J]. Crit Care Med, 1996,24(3) :381.
2Vincent J L, Fereira F, Moreno R. Scoring systems for assessing organ dysfunction and survival[J]. Crit Care Clin, 2000,16(2) :353.
3Gutteridge JM, Mitchell J. Redox imbalance in the critically iii. Br Med Bull[J], 1999,55(1) :49.
4Kotler DP. Cachexia[J]. Ann Intern Med, 2000, 133(8) :622
5Markos J, Hooper RO,Kavanagh - Gray D, et al. Effect of raised alveolar pressure on leukocyte retention in the lung[J]. J Appl Physiol, 1990, 69(1) :214.
6Johnson K, Aarden L, Choi Y, et al. The proinflammatory cytokine response to coagulation and endotoxin in whole blood[J]. Blood, 1996, 87(12) :5051.
7Natanson C, Hoffman WD, Suffredini AF,et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis[J].Ann Intern Med, 1994,120(9) :771.
8Bone R C, Fisher CJ Jr, Clemmer TP, et al. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome[J]. Chest, 1987,92(6): 1032.
9Fcex BA,Shelly MP. The eytokine response to critical illness[J]. J Accid Emerg Med, 1996,13(3): 154.
10Alejandria MM, Lansang MA, Mantaring JB. Intravenous immunoglobulin for treating sepsis and septic shock[J]. Cochrane Database of Systematic Reviews, 2000,2.
